New York Post
@nypost·2.4M subscribers·43.2K videos
Who’s taking Ozempic? New data reveals ‘significant’ shift, prompts shortage fears
Posted
July 28, 2024
Views
4,201
Likes
84
Comments
29
Engagement
2.69%
July 28, 2024
4,201
84
29
2.69%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
See what was published immediately before and after this episode.
0:46Now PlayingNo-zempic?
Ozempic-like drugs were originally developed to treat Type 2 diabetes — but authors of a new study say they are increasingly being used for weight loss instead. Now, there are fears of potential shortages.
“This data suggests that more healthcare providers are seeing the benefits of these medications for treating obesity, which is a significant public health shift,” said Dr. Yee Hui Yeo, a clinical fellow at Cedars-Sinai Medical Center in Los Angeles.
Read more at
#ozempic #health #news
The New York Post is your source for breaking news, news about New York, sports, business, entertainment, opinion, real estate, culture, fashion, and more.
Subscribe to New York Post Sports
Catch the latest news here
Follow The New York Post on:
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
